Stay updated with breaking news from Quant Biomarkers. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Xlife Sciences AG Key word Annual Results Xlife Sciences AG Publishes 2023 Annual Report 23Apr2024 0700 CETCEST Release of an ad hoc announcement pursuant to Art 53 LR The issuer is solely responsibl
Xlife Sciences AG / Key word: Annual Results Xlife Sciences AG Publishes 2023 Annual Report 23-Apr-2024 / 07:00 CET/CEST Release of an ad hoc announcement pursuant to Art. 53 LR The...
Xlife Sciences AG / Key word(s): Letter of Intent/PartnershipXlife Sciences AG paves the way for the next successful out-licensing and announces cooperation with Quant Biomarkers AG for the development of advanced biomarkers for kidney diseases 20.12.2023 / 07:00 CET/CESTXlife Sciences AG (SIX: XLS) and Quant Biomar...
The unified data-driven Biomarkers Platform specializes in the aggregation and synthesis of validated biomarker technologies for the development of sophisticated analytical products for Precision Medicine, Practical Human Longevity, InsurTech and InvestTechBASEL, Switzerland--(BUSINESS WIRE)--Deep Knowledge Group an...
The unified data-driven Biomarkers Platform specializes in the aggregation and synthesis of validated biomarker technologies for the development of sophisticated analytical products for Precision Medicine